(Q39928784)

15 September 2017

title

An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes (English)

1 reference

15 September 2017

W Kang

1

1 reference

15 September 2017

L Wang

2

1 reference

15 September 2017

H Harrell

3

1 reference

15 September 2017

J Liu

4

1 reference

15 September 2017

D L Thomas

5

1 reference

15 September 2017

T L Mayfield

6

1 reference

15 September 2017

M M Scotti

7

1 reference

15 September 2017

G J Ye

8

1 reference

15 September 2017

G Veres

9

1 reference

15 September 2017

D R Knop

10

1 reference

15 September 2017

language of work or name

1 reference

16 October 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

16

1 reference

15 September 2017

issue

2

1 reference

15 September 2017

page(s)

229-239

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2008.158

15 September 2017

exact match

0 references

cites work

Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

A Human Parvovirus, Adeno-Associated Virus, as a Eucaryotic Vector: Transient Expression and Encapsidation of the Procaryotic Gene for Chloramphenicol Acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Site-specific integration by adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus expressing CLN2 cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: alpha-, beta-, gamma-, or delta-sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Mutagenesis of an AUG codon in the adeno-associated virus rep gene: effects on viral DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Recent advances in recombinant adeno-associated virus vector production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Cell lines for the production of recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Novel tools for production and purification of recombinant adenoassociated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Production of recombinant adeno-associated type 5 (rAAV5) vectors using recombinant herpes simplex viruses containing rep and cap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Optimization of recombinant adeno-associated virus production using an herpes simplex virus amplicon system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Transfection-free and scalable recombinant AAV vector production using HSV/AAV hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Identification of a replication-defective herpes simplex virus for recombinant adeno-associated virus type 2 (rAAV2) particle assembly using stable producer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Insect cells as a factory to produce adeno-associated virus type 2 vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Efficient production of adeno-associated virus vectors using split-type helper plasmids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Bioreactor production of recombinant herpes simplex virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

The use of heterologous promoters for adeno-associated virus (AAV) protein expression in AAV vector production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Characterization of adeno-associated virus rep proteins in human cells by antibodies raised against rep expressed in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Mechanism of Host Restriction of Adenovirus-associated Virus Replication in African Green Monkey Kidney Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

A helper virus-free packaging system for recombinant adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Herpes simplex virus type 1 immediate-early gene expression is required for the induction of apoptosis in human epithelial HEp-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

ICP0 gene expression is a herpes simplex virus type 1 apoptotic trigger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

Targeted integration of adeno-associated virus (AAV) into human chromosome 19

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

7 January 2021

Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

7 January 2021

Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

7 January 2021

Role for highly regulated rep gene expression in adeno-associated virus vector production

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

7 January 2021

The herpes simplex virus type 1 regulatory protein ICP27 is required for the prevention of apoptosis in infected human cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2008.158

7 January 2021

Identifiers

DOI

10.1038/GT.2008.158

1 reference

15 September 2017

1 reference